No Increased Breast Cancer Risk With Menopausal Estrogen in BRCA Carriers

No Increased Breast Cancer Risk With Menopausal Estrogen in BRCA Carriers

(MedPage Today) -- SAN ANTONIO -- Menopausal hormone therapy (MHT) did not increase breast cancer risk in women with BRCA mutations, according to a study reported here. In fact, women who used estrogen-only MHT had a significantly lower risk...

HRT Does Not Adversely Affect Breast Cancer Risk in BRCA Variant Population

Estrogen alone was associated with a lower risk of BRCA-mutated breast cancer, according to data from an ongoing study.

HRT Use Does Not Raise Breast Cancer Risk in BRCA Carriers

Hormone therapy after breast cancer did not increase risk in BRCA1/2 carriers; estrogen alone was linked to lower risk.

HRT Shows No Adverse Effect on Breast Cancer Risk in Patients With BRCA Variant | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

New research reveals hormone replacement therapy may lower breast cancer risk in BRCA carriers, challenging existing medical guidelines on HRT use.